Large-scale testing (Phase 3)Study completedNCT04754594
What this trial is testing
To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older
Who this might be right for
SARS-CoV-2 InfectionCOVID-19Maternal Immunization
BioNTech SE 726